Successful management of severe Pneumocystis jirovecii pneumonia with inhaled nitric oxide and individualized ventilatory strategies in an immunosuppressed patient: a case report - Scorecard - MDSpire
Advertisement
Successful management of severe Pneumocystis jirovecii pneumonia with inhaled nitric oxide and individualized ventilatory strategies in an immunosuppressed patient: a case report
Clinical Scorecard: Effective Treatment of Severe Pneumocystis jirovecii Pneumonia Using Inhaled Nitric Oxide and Tailored Ventilation Approaches in an Immunocompromised Individual: A Case Study
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Immunocompromised individuals, particularly those receiving corticosteroids for checkpoint inhibitor pneumonitis, with a focus on risk factors for PJP.
Care Setting
Key Highlights
PJP is a life-threatening complication in non-HIV patients with a mortality rate of 30-60%.